216 related articles for article (PubMed ID: 33899326)
1. Allopurinol hepatotoxicity is associated with human leukocyte antigen Class I alleles.
Fontana RJ; Li YJ; Phillips E; Saeed N; Barnhart H; Kleiner D; Hoofnagle J;
Liver Int; 2021 Aug; 41(8):1884-1893. PubMed ID: 33899326
[TBL] [Abstract][Full Text] [Related]
2. The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine.
Fontana RJ; Cirulli ET; Gu J; Kleiner D; Ostrov D; Phillips E; Schutte R; Barnhart H; Chalasani N; Watkins PB; Hoofnagle JH
J Hepatol; 2018 Dec; 69(6):1317-1325. PubMed ID: 30138689
[TBL] [Abstract][Full Text] [Related]
3. Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗35:02 as a risk factor.
Urban TJ; Nicoletti P; Chalasani N; Serrano J; Stolz A; Daly AK; Aithal GP; Dillon J; Navarro V; Odin J; Barnhart H; Ostrov D; Long N; Cirulli ET; Watkins PB; Fontana RJ; ; ;
J Hepatol; 2017 Jul; 67(1):137-144. PubMed ID: 28323125
[TBL] [Abstract][Full Text] [Related]
4. HLA alleles influence the clinical signature of amoxicillin-clavulanate hepatotoxicity.
Stephens C; López-Nevot MÁ; Ruiz-Cabello F; Ulzurrun E; Soriano G; Romero-Gómez M; Moreno-Casares A; Lucena MI; Andrade RJ
PLoS One; 2013; 8(7):e68111. PubMed ID: 23874514
[TBL] [Abstract][Full Text] [Related]
5. Human Leukocyte Antigen B*14:01 and B*35:01 Are Associated With Trimethoprim-Sulfamethoxazole Induced Liver Injury.
Li YJ; Phillips EJ; Dellinger A; Nicoletti P; Schutte R; Li D; Ostrov DA; Fontana RJ; Watkins PB; Stolz A; Daly AK; Aithal GP; Barnhart H; Chalasani N;
Hepatology; 2021 Jan; 73(1):268-281. PubMed ID: 32270503
[TBL] [Abstract][Full Text] [Related]
6. Impact of the HLA-B(*)58:01 Allele and Renal Impairment on Allopurinol-Induced Cutaneous Adverse Reactions.
Ng CY; Yeh YT; Wang CW; Hung SI; Yang CH; Chang YC; Chang WC; Lin YJ; Chang CJ; Su SC; Fan WL; Chen DY; Wu YJ; Tian YC; Hui RC; Chung WH;
J Invest Dermatol; 2016 Jul; 136(7):1373-1381. PubMed ID: 26996548
[TBL] [Abstract][Full Text] [Related]
7. HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome/toxic epidermal necrolysis in a Portuguese population.
Gonçalo M; Coutinho I; Teixeira V; Gameiro AR; Brites MM; Nunes R; Martinho A
Br J Dermatol; 2013 Sep; 169(3):660-5. PubMed ID: 23600531
[TBL] [Abstract][Full Text] [Related]
8. HLA-B*58: 01 association in allopurinol-induced severe cutaneous adverse reactions: the implication of ethnicity and clinical phenotypes in multiethnic Malaysia.
Low DE; Nurul-Aain AF; Tan WC; Tang JJ; Bakhtiar MF; Murad S; Chang CC; Too CL; Tang MM
Pharmacogenet Genomics; 2020 Sep; 30(7):153-160. PubMed ID: 32433341
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
Kaniwa N; Saito Y
J Hum Genet; 2013 Jun; 58(6):317-26. PubMed ID: 23635947
[TBL] [Abstract][Full Text] [Related]
10. The Presence of HLA-B75, DR13 Homozygosity, or DR14 Additionally Increases the Risk of Allopurinol-Induced Severe Cutaneous Adverse Reactions in HLA-B*58:01 Carriers.
Shim JS; Yun J; Kim MY; Chung SJ; Oh JH; Kang DY; Jung JW; Cho SH; Kang HR
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1261-1270. PubMed ID: 30529060
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of the HLA-B
Park HW; Kim DK; Kim SH; Kim S; Chae DW; Yang MS; Oh YK; Lee JP; Jung JW; Shin J; Hwang JH; Kang MG; Kim SM; Kwon SK; Kim HY; Kim MH; Kim SJ; Ryu DR; Cho YJ; Jee YK; Kim SM; Lee EK; Kim JY; Cho HS; Jeong YY; Kim SH; Jun JB; Park JS; Kim GH; Kim S; Jung HY; Lee JM
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1271-1276. PubMed ID: 30580048
[TBL] [Abstract][Full Text] [Related]
12. Comparison between the
Saksit N; Nakkam N; Konyoung P; Khunarkornsiri U; Tassaneeyakul W; Chumworathayi P; Kanjanawart S; Sukasem C; Sangviroon A; Pattanacheewapull O; Tassaneeyakul W
J Immunol Res; 2017; 2017():2738784. PubMed ID: 29392141
[TBL] [Abstract][Full Text] [Related]
13. HLA-B*53:01 Is a Significant Risk Factor of Liver Injury due to Phenytoin and Other Antiepileptic Drugs in African Americans.
Nicoletti P; Dellinger A; Li YJ; Barnhart H; Phillips E; Chalasani N;
Am J Gastroenterol; 2024 Jan; 119(1):200-202. PubMed ID: 37552102
[TBL] [Abstract][Full Text] [Related]
14. An effective strategy to prevent allopurinol-induced hypersensitivity by HLA typing.
Jung JW; Kim DK; Park HW; Oh KH; Joo KW; Kim YS; Ahn C; Lee KW; Cho SH; Min KU; Kang HR
Genet Med; 2015 Oct; 17(10):807-14. PubMed ID: 25634024
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of HLA-B*5801 screening in severe allopurinol hypersensitivity syndrome: an updated systematic review and meta-analysis.
Yu KH; Yu CY; Fang YF
Int J Rheum Dis; 2017 Sep; 20(9):1057-1071. PubMed ID: 28857441
[TBL] [Abstract][Full Text] [Related]
16. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.
Hung SI; Chung WH; Liou LB; Chu CC; Lin M; Huang HP; Lin YL; Lan JL; Yang LC; Hong HS; Chen MJ; Lai PC; Wu MS; Chu CY; Wang KH; Chen CH; Fann CS; Wu JY; Chen YT
Proc Natl Acad Sci U S A; 2005 Mar; 102(11):4134-9. PubMed ID: 15743917
[TBL] [Abstract][Full Text] [Related]
17. Drug eruptions induced by allopurinol associated with HLA-B*5801.
Zeng M; Zhang M; Liu F; Yan W; Kong Q; Sang H
Indian J Dermatol Venereol Leprol; 2015; 81(1):43-5. PubMed ID: 25566896
[TBL] [Abstract][Full Text] [Related]
18. Analysis of HLA-B Allelic Variation and IFN-γ ELISpot Responses in Patients with Severe Cutaneous Adverse Reactions Associated with Drugs.
Klaewsongkram J; Sukasem C; Thantiworasit P; Suthumchai N; Rerknimitr P; Tuchinda P; Chularojanamontri L; Srinoulprasert Y; Rerkpattanapipat T; Chanprapaph K; Disphanurat W; Chakkavittumrong P; Tovanabutra N; Srisuttiyakorn C;
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):219-227.e4. PubMed ID: 29800753
[TBL] [Abstract][Full Text] [Related]
19. Allopurinol hypersensitivity is primarily mediated by dose-dependent oxypurinol-specific T cell response.
Yun J; Mattsson J; Schnyder K; Fontana S; Largiadèr CR; Pichler WJ; Yerly D
Clin Exp Allergy; 2013 Nov; 43(11):1246-55. PubMed ID: 24152157
[TBL] [Abstract][Full Text] [Related]
20. Detection of HLA-B*58:01, the susceptible allele for allopurinol-induced hypersensitivity, by loop-mediated isothermal amplification.
Kwok J; Kwong KM
Br J Dermatol; 2013 Mar; 168(3):526-32. PubMed ID: 23066948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
